CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Mahatme Sandesh Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | Fardis Maria Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-06-05 | High Katherine A Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-05-30 | Prasad Raju Chief Financial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2025-05-30 | Patel Naimish Chief Medical Officer | Grant or award · Restricted Stock Units | +25,000 | 25,000 | ||
| 2025-05-29 | Patel Naimish Chief Medical Officer | Sale | −3,932 | $35.94 | $141K | 6,068 |
| 2025-05-28 | Patel Naimish Chief Medical Officer | Option exercise | +10,000 | 10,000 | ||
| 2025-05-28 | Patel Naimish Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2025-04-03 | Patel Naimish Chief Medical Officer | Purchase | +1,508 | $32.96 | $50K | 1,508 |
| 2025-03-21 | Kulkarni Samarth Chief Executive Officer | Sale | −10,031 | $41.23 | $414K | 195,085 |
| 2025-03-21 | Bruno Julianne Chief Operating Officer | Sale | −1,714 | $41.23 | $71K | 10,544 |
| 2025-03-21 | Prasad Raju Chief Financial Officer | Sale | −2,197 | $41.23 | $91K | 16,767 |
| 2025-03-21 | KASINGER JAMES R. General Counsel and Secretary | Sale | −3,185 | $41.23 | $131K | 81,729 |
| 2025-03-20 | Kulkarni Samarth Chief Executive Officer | Option exercise | +19,688 | 205,116 | ||
| 2025-03-20 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −19,688 | 59,062 | ||
| 2025-03-20 | Bruno Julianne Chief Operating Officer | Option exercise | +3,750 | 12,258 | ||
| 2025-03-20 | Bruno Julianne Chief Operating Officer | Option exercise · Restricted Stock Units | −3,750 | 11,250 | ||
| 2025-03-20 | Prasad Raju Chief Financial Officer | Option exercise | +6,250 | 18,964 | ||
| 2025-03-20 | Prasad Raju Chief Financial Officer | Option exercise · Restricted Stock Units | −6,250 | 18,750 |
Page 8 of 46 · 910 trades